Ohio State University Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.osu.edu

Clinical Trials

Community Awareness Resources and Education - Project 1

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Behavioral: Lay Health Advisor Education Intervention
Behavioral: Usual Care Group

First Posted Date: 2010-07-29

Last Posted Date: 2023-03-23

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 280

Registration Number: NCT01172561

Locations: 🇺🇸
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

Phase 2

Completed

Conditions: Adenocarcinoma of the Esophagus
Adenocarcinomas of the Gastroesophageal Junction
Recurrent Esophageal Cancer
Stage IV Esophageal Cancer
Squamous Cell Carcinoma of the Esophagus

Interventions: Drug: pralatrexate
Drug: docetaxel
Radiation: fludeoxyglucose F 18
Procedure: positron emission tomography

First Posted Date: 2010-05-24

Last Posted Date: 2016-06-01

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT01129206

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States

Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma

Phase 1

Completed

Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx
Stage IV Squamous Cell Carcinoma of the Oropharynx

Interventions: Drug: vorinostat
Drug: cisplatin
Radiation: radiation therapy
Procedure: Correlative Studies

First Posted Date: 2010-02-09

Last Posted Date: 2019-06-04

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 27

Registration Number: NCT01064921

Locations: 🇺🇸
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy

Phase 1

Completed

Conditions: Prostate Cancer

First Posted Date: 2009-11-09

Last Posted Date: 2014-10-16

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 60

Registration Number: NCT01009736

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer

Phase 2

Withdrawn

Conditions: Breast Cancer

First Posted Date: 2009-11-05

Last Posted Date: 2015-03-26

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT01008514

Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Phase 2

Conditions: Leukemia

First Posted Date: 2009-11-01

Last Posted Date: 2014-01-10

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 180

Registration Number: NCT01005758

Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Not Applicable

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Metastatic Cancer

Interventions: Radiation: Radiation Therapy

First Posted Date: 2009-09-24

Last Posted Date: 2017-06-06

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT00983359

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma

Phase 2

Withdrawn

Conditions: Lymphoma

Interventions: Biological: rituximab
Biological: bleomycin sulfate
Drug: EPOCH regimen
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: etoposide
Drug: prednisone
Drug: vincristine sulfate

First Posted Date: 2009-09-24

Last Posted Date: 2017-11-30

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT00983944

Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy

Completed

Conditions: Endometrial Cancer

First Posted Date: 2009-05-29

Last Posted Date: 2018-04-02

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 142

Registration Number: NCT00909896

Locations: 🇺🇸
The Ohio State University, Columbus, Ohio, United States

Steep Trendelenburg Positioning on Intra-Ocular Pressure During Surgery for Endometrial Robotics Versus Laparotomy

Withdrawn

Conditions: Intraocular Pressure

First Posted Date: 2009-02-27

Last Posted Date: 2014-07-28

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT00852774

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy